Keytruda Injection(Pembrolizumab)

Before taking Keytruda Injection Pembrolizumab medicine To make sure Keytruda is safe for you, tell your doctor if you have a lung disease or a breathing disorder, liver or kidney disease, a thyroid disorder, an autoimmune disorder such as lupus, Crohn’s disease, or ulcerative colitis orif you have ever had an organ transplant. https://jonabiotech.com/

Do not use Keytruda Injection Pembrolizumab if you are pregnant. It could harm the unborn baby. Tell your doctor right away if you become pregnant during treatment. Use effective birth control while you are using this medicine and for at least 4 months after your last dose.

It is not known whether Keytruda Injection Pembrolizumab passes into breast milk or if it could harm a nursing baby. You should not breast-feed while using Keytruda Injection Pembrolizumab and for at least 4 months after your last dose.

Pembrolizumab (formerly lambrolizumab, brand name Keytruda) is a humanized antibody used in cancer immunotherapy. This includes to treat melanoma, lung cancer, head and neck cancer, Hodgkin lymphoma, and stomach cancer. It is given by slow injection into a vein.

KEYTRUDA is a prescription medicine used to treat:

a kind of skin cancer called melanoma.
It may be used when your melanoma has spread or cannot be removed by surgery (advanced melanoma), or
It may be used to help prevent melanoma from coming back after it and lymph nodes that contain cancer have been removed by surgery.
a kind of lung cancer called non–small cell lung cancer (NSCLC).
It may be used with the chemotherapy medicines pemetrexed and a platinum as your first treatment when your lung cancer has spread (advanced NSCLC) and is a type called “nonsquamous” and your tumor does not have an abnormal “EGFR” or “ALK” gene.
It may be used with the chemotherapy medicines carboplatin and either paclitaxel or paclitaxel protein-bound as your first treatment when your lung cancer has spread (advanced NSCLC) and is a type called “squamous.”
It may be used alone as your first treatment when your lung cancer has not spread outside your chest (stage III) and you cannot have surgery or chemotherapy with radiation, or your NSCLC has spread to other areas of your body (advanced NSCLC), and your tumor tests positive for “PD-L1” and does not have an abnormal “EGFR” or “ALK” gene.
It may also be used alone for advanced NSCLC if you have tried chemotherapy that contains platinum and it did not work or is no longer working and, your tumor tests positive for “PD-L1” and if your tumor has an abnormal “EGFR” or “ALK” gene, you have also received an “EGFR” or “ALK” inhibitor medicine that did not work or is no longer working.
a kind of cancer called head and neck squamous cell cancer (HNSCC).
It may be used with the chemotherapy medicines fluorouracil and a platinum as your first treatment when your head and neck cancer has spread or returned and cannot be removed by surgery.
It may be used alone as your first treatment when your head and neck cancer has spread or returned and cannot be removed by surgery, and your tumor tests positive for “PD-L1.”
It may be used alone when your head and neck cancer has spread or returned, and you have received chemotherapy that contains platinum and it did not work or is no longer working.
a kind of cancer called classical Hodgkin lymphoma (cHL). It may be used for cHL in adults and children when you have tried a treatment and it did not work or when your cHL has returned after you received 3 or more types of treatment.
a kind of cancer called primary mediastinal B-cell lymphoma (PMBCL). It may be used for PMBCL in adults and children when you have tried a treatment and it did not work or your PMBCL has returned after you received 2 or more types of treatment.
a kind of bladder and urinary tract cancer called urothelial carcinoma.
It may be used when your cancer has not spread to nearby tissue in the bladder, but is at high-risk for spreading (high-risk, non-muscle invasive bladder cancer [NMIBC]) and when your tumor is a type called “carcinoma in situ” (CIS), and you have tried treatment with Bacillus Calmette-Guerin (BCG) and it did not work, and you are not able to or have decided not to have surgery to remove your bladder.
It may be used when your bladder or urinary tract cancer has spread or cannot be removed by surgery (advanced urothelial cancer), and you are not able to receive chemotherapy that contains a medicine called cisplatin, and your tumor tests positive for “PD-L1,” or you are not able to receive a medicine called cisplatin or carboplatin, or you have received chemotherapy that contains platinum, and it did not work or is no longer working.
a kind of cancer that is shown by a laboratory test to be a microsatellite instability-high (MSI-H) or a mismatch repair deficient (dMMR) solid tumor. It may be used in adults and children to treat:
cancer that has spread or cannot be removed by surgery (advanced cancer), and
has progressed following treatment, and you have no satisfactory treatment options, or
you have colon or rectal cancer, and you have received chemotherapy with fluoropyrimidine, oxaliplatin, and irinotecan but it did not work or is no longer working.
It is not known if KEYTRUDA is safe and effective in children with MSI-H cancers of the brain or spinal cord (central nervous system cancers).
a kind of stomach cancer called gastric or gastroesophageal junction (GEJ) adenocarcinoma that tests positive for “PD-L1.” It may be used when your stomach cancer:
has returned or spread (advanced gastric cancer), and
you have received 2 or more types of chemotherapy including fluoropyrimidine and chemotherapy that contains platinum, and it did not work or is no longer working, and
if your tumor has an abnormal “HER2/neu” gene, you also received a HER2/neu‑targeted medicine and it did not work or is no longer working.
a kind of cancer called squamous cell carcinoma of the esophagus. It may be used when:
your cancer has returned or spread (advanced esophageal cancer), and
your tumor tests positive for “PD-L1,” and you have received one or more types of treatment and it did not work or is no longer working.
a kind of cancer called cervical cancer that tests positive for “PD-L1.” It may be used when your cervical cancer has returned or has spread or cannot be removed by surgery (advanced cervical cancer), and you have received chemotherapy, and it did not work or is no longer working.
a kind of liver cancer called hepatocellular carcinoma. It may be used after you have received the medicine sorafenib.
a kind of skin cancer called Merkel cell carcinoma (MCC) in adults and children. It may be used when your cancer has spread or returned.
a kind of kidney cancer called renal cell carcinoma (RCC). It may be used with the medicine axitinib as your first treatment when your kidney cancer has spread or cannot be removed by surgery (advanced RCC).